UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000022674
Receipt No. R000024686
Official scientific title of the study Study of celiac disease antibodies and IgG4 antibody in inflammatory bowel disease
Date of disclosure of the study information 2016/06/10
Last modified on 2018/12/11 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study of celiac disease antibodies and IgG4 antibody in inflammatory bowel disease
Title of the study (Brief title) Study of celiac disease antibodies and IgG4 antibody in IBD
Region
Japan

Condition
Condition Inflammatory bowel disease
Classification by specialty
Medicine in general Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to reveal clinical usefulness of celiac anntibodies and IgG4 antibody in inflammatory bowel disease
Basic objectives2 Others
Basic objectives -Others to reveal clinical usefulness of celiac anntibodies and IgG4 antibody in IBD
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes anti-gliadin IgG, anti-gliadin IgA,anti-tissue transglutaminase IgG,anti-tissue transglutaminase IgA,anti-deamidated gliadin peptide IgA,anti-deamidated gliadin peptide IgG,IgG4 antibody
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with Inflammatory bowel disease
Key exclusion criteria nothing
Target sample size 300

Research contact person
Name of lead principal investigator Manabu Ishii
Organization Kawasaki Medical School
Division name Gastroenterology Department of Internal Medicine
Address 577, Matsushima, Kurashiki city
TEL 086-462-1111
Email manabuisii@niji.or.jp

Public contact
Name of contact person Manabu Ishii
Organization Kawasaki Medical School
Division name Gastroenterology Department of Internal Medicine
Address 577, Matsushima, Kurashiki , Okayama 701-0192, Japan
TEL 086-462-1111
Homepage URL
Email manabuisii@niji.or.jp

Sponsor
Institute Kawasaki Medical School
Institute
Department

Funding Source
Organization Kawasaki Medical School
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 10 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2016 Year 03 Month 09 Day
Anticipated trial start date
2016 Year 06 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information None

Management information
Registered date
2016 Year 06 Month 09 Day
Last modified on
2018 Year 12 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024686